• Corpus ID: 21667697

Silencing of CCR 2 in myocarditis

@inproceedings{Leuschner2015SilencingOC,
  title={Silencing of CCR 2 in myocarditis},
  author={Florian Leuschner and Gabriel Courties and Partha Dutta and Luke J. Mortensen and Rostic Gorbatov and Brena F. Sena and Tatiana I. Novobrantseva and Anna Borodovsky and Kevin Fitzgerald and Victor E. Koteliansky and Yoshiko Iwamoto and Marina Bohlender and Soeren Meyer and Felix Lasitschka and Benjamin Meder and Hugo A. Katus and Charles P. Lin and Peter Libby and Filip K. Swirski and Daniel G. Anderson and Ralph Weissleder and Matthias Nahrendorf},
  year={2015}
}
Florian Leuschner1,2,3*, Gabriel Courties1, Partha Dutta1, Luke J. Mortensen1, Rostic Gorbatov1, Brena Sena1, Tatiana I. Novobrantseva4, Anna Borodovsky4, Kevin Fitzgerald4, Victor Koteliansky5, Yoshiko Iwamoto1, Marina Bohlender2,3, Soeren Meyer2,3, Felix Lasitschka6, Benjamin Meder2,3, Hugo A. Katus2,3, Charles Lin1, Peter Libby7, Filip K. Swirski1, Daniel G. Anderson5,8,9,10, Ralph Weissleder1,11, and Matthias Nahrendorf1* 
watermark.silverchair.com
10 Citations
Background Citations
1

Figures from this paper

10 Citations

Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications

The present is a comprehensive review of the immunopathology of Covid-19 and discusses how immune modifying drugs, such as tocilizumab, chloroquine, glucocorticoids and immunoglobulins, and blood purification therapy, can constitute a fundamental moment in the therapy of the infection.

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential

This review will serve to provide a general overview of the connection between various chemokines and their receptors with atherosclerosis and the different developments, including mouse models and clinical trials that tackle this complex interplay.

Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction.

An overview of cardiac macrophages' provenance in the contexts of cardiac homeostasis and stress is given and the recently identified mechanism by which these cells regulate electrical conduction in the atrioventricular node is highlighted.

My Transition From a Postdoctoral Fellowship in the United States to Junior Faculty in Europe: Challenges and Opportunities.

The finding that monocytes reside in the spleen and are released on myocardial injury fueled the frenzy for this leukocyte subset even further and ignited various projects in the following years.

Electroimmunology and cardiac arrhythmia

The knowledge gap between electrophysiology and immunology is bridged, to promote conceptual connections between these two fields and to explore the roles of leukocytes in cardiac conduction and arrhythmia.

The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease

Key biomarkers up-regulated in the immune-fibrosis axis are discussed and the promising molecular imaging agents to reveal this critical pathological process are summarized.

Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

This review is particularly intended to bridge the knowledge gap between cardiologists and regenerative nanomedicine experts, and help pave the way for developing novel, safer, and more effective approaches that will enable the medical community to reduce morbidity and mortality in HF patients.

Chronic Heart Failure and Inflammation: What Do We Really Know?

This review will present what is currently known about inflammation in chronic HF in both humans and animal models as a means to highlight the gap in the knowledge base that requires further examination.

Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era

This review introduces the mechanisms of different targeted therapies, and mainly describes the targeted therapy applied in the CVDs, and makes comparative analysis to clarify the advantages and disadvantages.

References

SHOWING 1-10 OF 36 REFERENCES

The management of myocarditis.

The gaps in current clinical knowledge, particularly with respect to aetiology-based therapy, are emphasized, and opportunities for high impact, translational investigations are suggested.

Enhanced expression and production of monocyte chemoattractant protein‐1 in myocarditis

MCP‐1 may play an important role in the pathogenesis of human acute myocarditis as well as in the progression of rat EAM.

Myocarditis: Infection Versus Autoimmunity

  • N. Rose
  • Medicine, Biology
    Journal of Clinical Immunology
  • 2009
Using coxsackievirus B3 infection or cardiac myosin immunization, some critical steps leading from a self-limited viral myocarditis to chronic autoimmune myCarditis and sometimes, to dilated cardiomyopathy are identified.

Therapeutic siRNA silencing in inflammatory monocytes

An optimized lipid nanoparticle and a CCR2-silencing short interfering RNA that, when administered systemically in mice, show rapid blood clearance, accumulate in spleen and bone marrow, and localize to monocytes prevent their accumulation in sites of inflammation.

Myocarditis

Autoimmune myocarditis: past, present and future.

Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response

The current literature regarding the effects of infection on haematopoietic stem cell function and how these effects may have a pivotal role in directing the immune response from the bone marrow are summarized.

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

The results do not support routine treatment of myocarditis with immunosuppressive drugs, but long-term mortality was high and patients with a vigorous inflammatory response had less severe disease.

Heart-Infiltrating Prominin-1+/CD133+ Progenitor Cells Represent the Cellular Source of Transforming Growth Factor &bgr;–Mediated Cardiac Fibrosis in Experimental Autoimmune Myocarditis

Taking together, heart-infiltrating prominin-1+ progenitors are the major source of subsequent TGF-&bgr;–triggered cardiac fibrosis in experimental autoimmune myocarditis, and recognizing the critical, cytokine-dependent role of bone marrow–derived progenitor in cardiac remodeling might result in novel treatment concepts against inflammatory heart failure.

Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1α in Induction of Experimental Autoimmune Myocarditis and Effective Anti–Monocyte Chemoattractant Protein-1 Gene Therapy

Overall, these findings suggest that the chemokines MCP-1 and MIP-1α, acting through their receptors CCR2 and CCR5, are important in the induction of EAM and that inhibition of M CP-1 with 7ND gene transfection significantly reduced disease severity.